BERN, Switzerland, Dec. 01, 2022 (GLOBE NEWSWIRE) -- RetinAI Medical AG (“RetinAI”), a leader in developing software solutions for image processing and artificial intelligence in Ophthalmology, is ...

Given that the EU and FDA definitions of what constitutes a medical device encompass a large majority of medical products other than drugs, it is small wonder that the collective term ‘medical ...

Bern, Switzerland, 1 December 2022 – RetinAI Medical AG (“RetinAI”), a leader in developing software solutions for image processing and artificial intelligence in Ophthalmology, is proud to launch ...

Features of the Discovery CORE platform displayed include the overlay of AI on OCT images to visualize fluid and layers, side-by-side imaging comparisons on two different time-points or visits, and at ...